Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Safety data At least one treatment-emergent adverse event occurred in 86.4% of all participants, with a similar proportion of orforglipron participants experiencing an adverse event as placebo
Know your options : If GLP-1s arent sustainable, other medications or bariatric surgery might be a better long-term solution
Parenteral administration, which includes subcutaneous injections, is the most common route for GLP-1 receptor agonists
Graphical illustration of study design eFigure 2
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
